Menopause did not speed up disability in women with MS

Credibility

Interest

Share:1 min read

Key Takeaway

Menopause was not linked to faster disability worsening in women whose MS began with relapses.

What They Found

Researchers compared disability changes before and after menopause. Menopause was not linked to a higher risk of lasting disability worsening. It was also not linked to a higher risk of developing secondary progressive MS (a form with steady worsening after relapses). In women followed through menopause, disability ratings did not begin worsening faster at menopause. The findings suggest menopause was not the leading factor behind disability worsening in this group.

Who Should Care and Why

This study examined women in Australia whose MS began with relapses. The main analysis included women with repeated disability ratings and a reported menopause status. Researchers also studied women with disability ratings recorded both before and after menopause. The study focused on whether menopause changed the course of disability. It did not study people whose MS began without relapses.

Important Considerations

You should know the main analysis included 987 women, using previously collected health records and surveys. A smaller analysis followed 209 women across menopause. The study found no link, but it cannot prove menopause has no effect on disability.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Living with MS MS Progression

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News